8,816 Shares in Amedisys, Inc. (NASDAQ:AMED) Bought by Teacher Retirement System of Texas

Teacher Retirement System of Texas bought a new stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 8,816 shares of the health services provider's stock, valued at approximately $817,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Norges Bank bought a new position in Amedisys during the fourth quarter valued at $83,061,000. Pentwater Capital Management LP grew its holdings in Amedisys by 178.3% during the 4th quarter. Pentwater Capital Management LP now owns 1,180,000 shares of the health services provider's stock worth $107,132,000 after acquiring an additional 756,000 shares in the last quarter. AQR Arbitrage LLC grew its holdings in Amedisys by 59.1% during the 4th quarter. AQR Arbitrage LLC now owns 471,965 shares of the health services provider's stock worth $42,812,000 after acquiring an additional 175,311 shares in the last quarter. Birnam Oak Advisors LP bought a new stake in shares of Amedisys in the 4th quarter valued at about $15,832,000. Finally, Toronto Dominion Bank bought a new stake in shares of Amedisys in the 4th quarter valued at about $15,801,000. Institutional investors own 94.36% of the company's stock.

Amedisys Stock Performance

NASDAQ AMED traded up $0.02 on Friday, hitting $97.49. 91,801 shares of the company's stock traded hands, compared to its average volume of 412,326. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.27. Amedisys, Inc. has a 1-year low of $82.15 and a 1-year high of $98.95. The firm's 50-day moving average price is $95.97 and its two-hundred day moving average price is $93.69. The firm has a market capitalization of $3.20 billion, a PE ratio of 35.97, a P/E/G ratio of 1.32 and a beta of 0.94.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, beating the consensus estimate of $1.13 by $0.12. The business had revenue of $594.78 million during the quarter, compared to analysts' expectations of $597.43 million. Amedisys had a net margin of 3.79% and a return on equity of 12.52%. The business's quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.03 EPS. As a group, analysts expect that Amedisys, Inc. will post 4.4 EPS for the current year.

Wall Street Analysts Forecast Growth

AMED has been the subject of a number of recent analyst reports. Royal Bank Of Canada reiterated an "outperform" rating and issued a $100.00 target price on shares of Amedisys in a research note on Wednesday, April 16th. Wall Street Zen cut shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, Amedisys currently has an average rating of "Hold" and a consensus price target of $100.75.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.